![Uday Saxena](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uday Saxena
Corporate Officer/Principal at
Dr. Reddy's Laboratories, Inc.
Profile
Uday Saxena is the founder of WT FABA Biocatalyst LLP, founded in 2025.
Dr. Saxena is currently the Chief Scientific Officer at Dr. Reddy's Laboratories, Inc. Former positions include Independent Director at Statera Biopharma, Inc. from 2022 to 2023, Principal at AtheroGenics, Inc., Chief Scientific Officer at Dr. Reddy's Laboratories Ltd., Member at American Diabetes Association, Advisor at Orchard Venture Partners, and Member at Alzheimer’s Association.
Education includes a doctorate from Memorial University of Newfoundland.
Uday Saxena active positions
| Companies | Position | Start |
|---|---|---|
Dr. Reddy's Laboratories, Inc.
 Dr. Reddy's Laboratories, Inc. Medical/Nursing ServicesHealth Services Develops pharmaceuticals products | Corporate Officer/Principal | - |
Former positions of Uday Saxena
| Companies | Position | End |
|---|---|---|
| STATERA BIOPHARMA, INC. | Director/Board Member | 12/01/2023 |
Alzheimer’s Association
 Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services Noncommercial Research Organizations | Corporate Officer/Principal | - |
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Corporate Officer/Principal | - |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Corporate Officer/Principal | - |
Training of Uday Saxena
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Dr. Reddy's Laboratories Ltd.
 Dr. Reddy's Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
Memorial University of Newfoundland
 Memorial University of Newfoundland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Commercial Services |
Orchard Venture Partners
 Orchard Venture Partners Investment ManagersFinance Orchard Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of technology and medical sectors. It provides financing for early and later-stage capital requirements. | Finance |
Alzheimer’s Association
Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services Noncommercial Research Organizations | Commercial Services |
Dr. Reddy's Laboratories, Inc.
Dr. Reddy's Laboratories, Inc. Medical/Nursing ServicesHealth Services Develops pharmaceuticals products | Health Services |
Statera Biopharma, Inc.
 Statera Biopharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Health Technology |
- Stock Market
- Insiders
- Uday Saxena
